Drug-induced acute liver failure

被引:80
作者
Larrey, D
Pageaux, GP
机构
[1] Hop St Eloi, Montpellier Sch Med, Dept Gastroenterol Hepatol & Liver Transplantat, F-34295 Montpellier 5, France
[2] INSERM, U632, Montpellier, France
关键词
drug hepatotoxicity; acute hepatitis; liver failure; epidemiology; liver transplantation;
D O I
10.1097/00042737-200502000-00002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Acute liver failure is the most severe expression and represents the first cause of fatalities related to drugs. As a consequence, it is also the first cause of drug withdrawal from the pharmaceutical market. The incidence of drug-induced hepatotoxicity in the general population has been recently estimated to be around 14/100 000 inhabitants in a Western country. Drugs appear to be responsible for 10-52% of all causes of acute liver failure. In Western countries, paracetamol (acetaminophen) represents the first cause of all liver failures. The contribution of non-paracetamol drugs given at normal doses is equivalent to that of combined viral hepatitis A and B. The natural prognosis varies between drugs. The spontaneous mortality rate ranges from 32% to 50% for paracetamol intoxication and more than 75% for other drugs. The preventive occurrence of drug hepatotoxicity and the course to acute liver failure is rather limited. It is recommended to stop the administration of a suspected drug when alanine aminotransferase levels increase to more than 3-5 times the upper limit of normal. In paracetamol intoxication, the rapid administration of N-acetylcysteine is a classical antidote. At the stage of liver failure, treatment is mostly supportive. Since irreversible damage is unpredictable, early transfer to a transplantation centre should be considered. (c) 2005 Lippincott Williams A Wilkins.
引用
收藏
页码:141 / 143
页数:3
相关论文
共 14 条
[1]  
BERNUAU J, 1999, OXFORD TXB CLIN HEPA, V2, P1341
[2]   Epidemiology and individual susceptibility to adverse drug reactions affecting the liver [J].
Larrey, D .
SEMINARS IN LIVER DISEASE, 2002, 22 (02) :145-155
[3]   Drug-induced liver diseases [J].
Larrey, D .
JOURNAL OF HEPATOLOGY, 2000, 32 :77-88
[4]  
Larrey Dominique, 1997, Journal of Hepatology, V26, P47, DOI 10.1016/S0168-8278(97)82333-1
[5]   Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States [J].
Ostapowicz, G ;
Fontana, RJ ;
Schiodt, FV ;
Larson, A ;
Davern, TJ ;
Han, SHB ;
McCashland, TM ;
Shakil, AO ;
Hay, JE ;
Hynan, L ;
Crippin, JS ;
Blei, AT ;
Samuel, G ;
Reisch, J ;
Lee, WM .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (12) :947-954
[6]  
Pessayre D, 1999, OXFORD TXB CLIN HEPA, P1261
[7]   Are patients with elevated liver tests at increased risk of drug-induced liver injury? [J].
Russo, MW ;
Watkins, PB .
GASTROENTEROLOGY, 2004, 126 (05) :1477-1480
[8]   Complementary and alternative medicine in chronic liver disease [J].
Seeff, LB ;
Lindsay, KL ;
Bacon, BR ;
Kresina, TF ;
Hoofnagle, JH .
HEPATOLOGY, 2001, 34 (03) :595-603
[9]   Incidence of drug-induced hepatic injuries: A French population-based study [J].
Sgro, C ;
Clinard, F ;
Ouazir, K ;
Chanay, H ;
Allard, C ;
Guilleminet, C ;
Lenoir, C ;
Lemoine, A ;
Hillon, P .
HEPATOLOGY, 2002, 36 (02) :451-455
[10]   Non-paracetamol drug-induced fulminant hepatic failure among adults in Scotland [J].
Smith, IDM ;
Simpson, KJ ;
Garden, OJ ;
Wigmore, SJ .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (02) :161-167